Teva Pharmaceutical Industries CEO Kåre Schultz's 2020 pay jumps 36% to $16M

Teva Pharmaceutical Industries reports 2020 executive compensation

By ExecPay News

Published: April 21, 2021

Teva Pharmaceutical Industries reported fiscal year 2020 executive compensation information on April 21, 2021.

In 2020, five executives at Teva Pharmaceutical Industries received on average a compensation package of $6.3M, a 41% increase compared to previous year.

Average pay of disclosed executives at Teva Pharmaceutical Industries

Kåre Schultz, Chief Executive Officer, received $16M in total, which increased by 36% compared to 2019. 64% of Schultz's compensation, or $10M, was in stock awards. Schultz also received $3.1M in non-equity incentive plan, $2M in salary, as well as $669K in other compensation.

Hafrun Fridriksdottir, Executive Vice President, Global Research and Development, received a compensation package of $4.3M, which decreased by 2% compared to previous year. 47% of the compensation package, or $2M, was in stock awards.

Brendan O'Grady, Executive Vice President, North America Commercial, earned $4.1M in 2020, a 19% increase compared to previous year.

Eric Drap, Executive Vice President, Global Operations, received $3.8M in 2020.

Eli Kalif, Chief Financial Officer, earned $3.7M in 2020, a 18016% increase compared to previous year.